Literature DB >> 8010703

Malignant transformation of a necrotic melanocytoma of the choroid in an amblyopic eye.

M Leidenix1, N Mamalis, R Goodart, R Harrie, C Kjeldsberg.   

Abstract

A 26-year-old man presented with an insidious loss of vision OD. He had amblyopia OD as a child secondary to congenital esotropia. Ophthalmic examination revealed a large mass beneath his right retina near the posterior pole. He also had glaucoma and a rapidly developing cataract. Ultrasound detected a choroidal mass, which was consistent with a melanoma. The patient chose enucleation over radiation therapy as his treatment modality. Pathologic evaluation of the tumor revealed a necrotic melanocytoma with a large malignant melanoma arising from its center that was comprised mainly of epithelioid cells. Malignant melanoma arising in a necrotic melanocytoma is an extremely rare event, and we believe this to be the first description of this event in a young patient with an amblyopic eye.

Entities:  

Mesh:

Year:  1994        PMID: 8010703

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  4 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Finding malignant change in a necrotic choroidal melanocytoma: a clinical challenge.

Authors:  M Kurli; P T Finger; T Manor; S A McCormick; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle.

Authors:  Henna Anu-Liisa Oittinen; Michael O'Shaughnessy; Anthony B Cullinane; Catherine Keohane
Journal:  J Clin Pathol       Date:  2007-06-01       Impact factor: 3.411

4.  Malignant transformation of iris melanocytoma to iris ring melanoma.

Authors:  Mandeep S Sagoo; Prithvi Mruthyunjaya; Ian Cree; Philip J Luthert; John L Hungerford
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.